U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C10H12N2O8.2Co
Molecular Weight 406.0773
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DICOBALT EDETATE

SMILES

[Co++].[Co++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O

InChI

InChIKey=TWAWHTJKASJPEK-UHFFFAOYSA-J
InChI=1S/C10H16N2O8.2Co/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;/q;2*+2/p-4

HIDE SMILES / InChI

Molecular Formula C10H12N2O8
Molecular Weight 288.2109
Charge -4
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Co
Molecular Weight 58.933195
Charge 2
Count
MOL RATIO 2 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Dicobalt edetate was developed as a cyanide antidote based on the known ability of cobalt to form stable complexes with cyanide. One current cobalt-based antidote available in Europe is dicobalt-EDTA, sold as Kelocyanor. This agent chelates cyanide as the cobalticyanide. This drug provides an antidote effect more quickly than formation of methemoglobin. It can be very toxic and cause seizures, upper airway oedema, chest pain, hypotension, vomiting, rashes and dyspnoea especially in those who have not be exposed to cyanide.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
SWITCH C Hi Mineral
Primary
Unknown
Curative
KELOCYANOR

Cmax

ValueDoseCo-administeredAnalytePopulation
9.8 μg/mL
4.28 mg/kg single, intravenous
COBALT plasma
Sus scrofa

AUC

ValueDoseCo-administeredAnalytePopulation
518 μg × min/mL
4.28 mg/kg single, intravenous
COBALT plasma
Sus scrofa

T1/2

ValueDoseCo-administeredAnalytePopulation
136 min
4.28 mg/kg single, intravenous
COBALT plasma
Sus scrofa

PubMed

Sample Use Guides

In Vivo Use Guide
Rabbits: Rabbits receiving 50 mg/Kg of elemental cobalt intravenously, given as cobalt disodium ethylenediamine tetra-acetate (Cobalt Disodium Edetate), showed no detectable toxic symptoms. Approximately 100 mg/Kg elemental cobalt, administered as rapidly as possible, still produced no toxic symptoms except for a questionable increase in respiratory rate.
Route of Administration: Intravenous
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
UKC6GH80QR
Record Status Validated (UNII)
Record Version